Quantitative and qualitative aspects of topoisomerase I and II alpha and beta in untreated and platinum/cyclophosphamide treated malignant ovarian tumors. [electronic resource]
- Cancer research Feb 1994
- 749-55 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
0008-5472
Antineoplastic Combined Chemotherapy Protocols--therapeutic use Blotting, Western Cell Cycle--physiology Cyclophosphamide--administration & dosage DNA Damage DNA Topoisomerases, Type I--analysis DNA Topoisomerases, Type II--analysis DNA, Neoplasm--analysis Female Flow Cytometry Humans Isoenzymes--antagonists & inhibitors Organoplatinum Compounds--administration & dosage Ovarian Neoplasms--drug therapy Teniposide--pharmacology Topoisomerase I Inhibitors Topoisomerase II Inhibitors